01 Greater Adoption of Smooth-Surface Implant Technologies Greater attention to implant surface safety and patient risk is supporting the adoption of smooth-surface implant technologies, as the FDA states that BIA-ALCL occurs more frequently with textured implants than with smooth implants; in its June 2024 data, 73% of 1,380 reported BIA-ALCL cases involved textured implants, compared with 3% involving smooth implants, although the agency notes that passive reporting data cannot determine incidence or prevalence.
02 Shift Toward Hybrid Breast Augmentation Using Implants and Fat Grafting Demand for more natural-looking augmentation and alternatives to implants is also supporting hybrid procedures that combine implants with autologous fat grafting, with fat transfer gaining popularity as patients seek added shape and contouring alongside implant-based volume enhancement
01 Growth in Neurosurgical Procedures and Expansion of Neurodiagnostic Centers and Specialized Clinics Drive Market The growth in neurosurgical procedures is increasing demand for brain monitoring systems that help clinicians assess neurological function during complex interventions. Higher procedure volumes create greater requirements for EEG, intracranial monitoring, and intraoperative neurophysiological monitoring equipment. For example, intraoperative monitoring can help surgical teams track neural activity and identify potential neurological changes during brain or spine procedures. Greater use of these procedures increases procurement of monitoring equipment and related accessories by hospitals. This expanding surgical application base therefore supports demand in the brain monitoring market.The expansion of neurodiagnostic centers and specialized clinics is increasing demand for brain monitoring equipment by creating more facilities dedicated to neurological assessment and disease management. A broader network of specialized centers increases testing capacity for conditions that require EEG and other neurological monitoring methods. For example, specialized epilepsy clinics use EEG monitoring to evaluate abnormal electrical brain activity and support clinical diagnosis. Higher testing capacity increases purchases of monitoring systems and related services, expanding the equipment supply requirements of healthcare providers. The growing neurodiagnostic infrastructure therefore supports market demand.
01 Concerns Over Implant Rupture and Capsular Contracture and Patient Concerns About Long-Term Implant Safety Restrain Market Expansion Implant rupture and capsular contracture can lead to pain, changes in breast shape, discomfort, and the need for additional medical procedures. These complications can increase follow-up and revision requirements and create concerns about the long-term outcomes of breast implants. Such risks can reduce patient willingness to undergo augmentation and limit market adoption.Uncertainty about the long-term safety and durability of breast implants can influence patients’ decisions to undergo augmentation procedures. Concerns about potential complications, implant longevity, and the need for future replacement can increase hesitation among prospective patients. This caution can reduce procedure demand and slow market growth.
01 Expansion of Breast Augmentation Tourism and Development of Personalized Implant Planning Offer Growth Opportunities Medical-tourism agencies, cosmetic surgery clinics, and implant providers can target international patients seeking breast augmentation with coordinated treatment and travel services. Companies such as Medigo can create revenue through patient referrals, treatment coordination, and healthcare-travel partnerships. Bundled medical-tourism services can add revenue beyond the surgical procedure itself.Plastic surgeons, implant manufacturers, and digital-health providers can use 3D imaging and planning software to support implant selection based on individual anatomy. Companies such as Canfield Scientific can generate revenue through imaging systems, surgical-planning software, and clinic partnerships. Digital planning tools can also create recurring software and service income.
01 Product Selection and Customization Complexity and Product Recalls and Market Disruptions Hinders Growth Manufacturers must address varying requirements for implant shape, size, surface, placement, and patient anatomy, increasing portfolio and clinical-support complexity. The FDA notes that surgeons select among different implant characteristics based on individual patient goals and anatomical considerations, making standardized product adoption more difficult.Breast implant recalls can reduce product availability and make healthcare providers more cautious about adopting specific implant types. For example, the FDA requested Allergan's worldwide recall of BIOCELL textured implants in 2019, requiring unused products to be returned and disrupting established supply channels.
January 2026 Establishment Labs expanded the availability of its Motiva Preservé breast augmentation technology in additional markets, focusing on minimally invasive augmentation procedures designed to reduce tissue disruption, improve recovery time, and support natural aesthetic outcomes. The technique integrates Motiva’s SmoothSilk Ergonomix implants with specialized surgical instruments and preservation-focused approaches.
August 2025 Mentor Worldwide LLC (Johnson & Johnson MedTech) received approval for process modifications associated with its MENTOR™ MemoryShape™ Breast Implants, enabling updates to final finished device testing procedures while maintaining product availability for augmentation and reconstruction applications.
July 2025 Polytech Health & Aesthetics expanded its breast implant innovation initiatives by strengthening its portfolio of silicone implant technologies, including customized implant options designed for aesthetic surgery applications across European and international markets.
June 2025 GC Aesthetics (GCA) continued expansion of its breast implant portfolio with increased adoption of its PERLE™ breast implant technology, supporting surgeons with advanced implant surfaces and designs aimed at improving patient-specific augmentation outcomes.